Out-of-Hospital Mortality Following TAVR: Decrypting the Enigma
- PMID: 33541538
- DOI: 10.1016/j.jcin.2020.11.022
Out-of-Hospital Mortality Following TAVR: Decrypting the Enigma
Keywords: TAVR; mortality; outcomes.
Conflict of interest statement
Funding Support and Author Disclosures Dr. Asgar has been a consultant for Edwards Lifesciences, Medtronic, and Abbott Structural. Dr. Jamart has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Evaluating Out-of-Hospital 30-Day Mortality After Transfemoral Transcatheter Aortic Valve Replacement: An STS/ACC TVT Analysis.JACC Cardiovasc Interv. 2021 Feb 8;14(3):261-274. doi: 10.1016/j.jcin.2020.10.027. JACC Cardiovasc Interv. 2021. PMID: 33541537
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
